MedTrace Logo

ECMO for Lung Transplantation in Cystic Fibrosis Patients

NCT03919604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-04-18

No results posted yet for this study

Summary

Cystic fibrosis (CF) is the most common genetically inherited disease in the Caucasian population. Bilateral lung transplantation (LUTX) is a viable option for these patients.

Frequently, the surgical operation of LUTX is complicated by hemodynamic instability, intractable hypoxia and respiratory acidosis. For these reasons, Intraoperative extracorporeal life support - ECLS- is required. Data on predictors of use of intraoperative ECLS in CF patients undergoing LUTX is scarce. Aim of this retrospective observational study was 1) to find possible risk factors at the time of enlistment associated with the intraoperative use of ECLS and 2) to compare the outcomes of CF patients treated with ECLS during LUTX or not.

Conditions

Interventions

PROCEDURE

Extracorporeal Life Support

Any extracorporeal blood treatment technique for respiratory and/or cardiac support

Sponsors & Collaborators

  • Policlinico Hospital

    lead OTHER

Principal Investigators

  • Giacomo Grasselli · Universita' di Milano

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03919604 on ClinicalTrials.gov